We use cookies to measure traffic and show relevant ads. By clicking Accept you agree to our use of analytics and advertising cookies.
EMA对口服司美格鲁肽（Wegovy片剂）的决策分析。OASIS 4数据、爱尔兰投资及与礼来的竞争。阅读预测与隐藏风险。
